Serum Fetuin Level in Polycystic Ovary Syndrome

August 4, 2019 updated by: Aljazeera Hospital

Serum Fetuin Level as a Marker in Polycystic Ovary Syndrome

polycystic ovary syndrome is a common gynecological problem

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Understanding the pathophysiology and the cause is of much importance for proper management of this problem

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Giza, Egypt
        • Recruiting
        • Algazeerah and Kasralainy hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 42 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

women who have PCOS and have symptoms of hyperandrogenism and irregular cycles

Description

Inclusion Criteria:

  • women who have PCOS in group 1 and who donnot have PCOS in group 2 with age between 20 -42 years

Exclusion Criteria:

  • women above 42 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
PCOS group
women who have PCOS
Diagnostic test: measurement of Fetuin-A level in serum
Fetuin A level will be measured in blood of the PCOS women
Other Names:
  • Fwtuin A level
control group
women who donnot have PCOS
Diagnostic test: measurement of Fetuin-A level in serum
Fetuin A level will be measured in blood of the PCOS women
Other Names:
  • Fwtuin A level

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of women who will have high level of fetuin A and has PCOS
Time Frame: within a week
Evaluation of women who have PCOS in relation to fetuin A level
within a week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Aljazeera Hospital

Collaborators

Cairo University
National Research Centre, Egypt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2019

Primary Completion (Anticipated)

February 1, 2020

Study Completion (Anticipated)

February 5, 2020

Study Registration Dates

First Submitted

January 25, 2019

First Submitted That Met QC Criteria

January 25, 2019

First Posted (Actual)

January 29, 2019

Study Record Updates

Last Update Posted (Actual)

August 6, 2019

Last Update Submitted That Met QC Criteria

August 4, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Fetuin

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Polycystic Ovary

Clinical Trials on measurement of Fetuin-A level in serum

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe